Acalabrutinib capsules or tablets are taken twice daily.Acalabrutinib FDA approval was granted on October 31, 2017, for treating MCL. Its approval was later expanded to include CLL and SLL. Acalabrutinib (brand name Calquence) is manufactured by AstraZeneca Pharmaceuticals.How does acalabrutinib...